Cargando…

MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53

Poor prognosis of hepatocellular carcinoma (HCC) patients is frequently associated with rapid tumor growth, recurrence and drug resistance. MT1G is a low-molecular weight protein with high affinity for zinc ions. In the present study, we investigated the expression of MT1G, analyzed clinical signifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yingchao, Wang, Gaoxiong, Tan, Xionghong, Ke, Kun, Zhao, Bixing, Cheng, Niangmei, Dang, Yuan, Liao, Naishun, Wang, Fei, Zheng, Xiaoyuan, Li, Qin, Liu, Xiaolong, Liu, Jingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858331/ https://www.ncbi.nlm.nih.gov/pubmed/31732712 http://dx.doi.org/10.1038/s41389-019-0176-5

Ejemplares similares

An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
por: Zhao, Bixing, et al.
Publicado: (2019)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
por: Zhong, Yue, et al.
Publicado: (2021)

LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
por: Wang, Yingchao, et al.
Publicado: (2023)

Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
por: You, Song, et al.
Publicado: (2022)

Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis
por: Zhao, Bixing, et al.
Publicado: (2019)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model
por: Liao, Naishun, et al.
Publicado: (2020)

Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion
por: Liao, Naishun, et al.
Publicado: (2019)

Lnc-PLA2G4A-4 facilitates the progression of hepatocellular carcinoma by inducing versican expression via sponging miR-23b-3p
por: Xiong, Jiahui, et al.
Publicado: (2023)

Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma
por: Xing, Xiaohua, et al.
Publicado: (2021)

HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis
por: Zhao, Bixing, et al.
Publicado: (2020)

Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
por: Liao, Naishun, et al.
Publicado: (2017)

4E-BP1(Thr46) Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC
por: Lin, Xincong, et al.
Publicado: (2020)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

High expression of B7-H2 or B7-H3 is associated with poor prognosis in hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2019)

Poly (dopamine) coated superparamagnetic iron oxide nanocluster for noninvasive labeling, tracking, and targeted delivery of adipose tissue-derived stem cells
por: Liao, Naishun, et al.
Publicado: (2016)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition
por: Xie, Haihua, et al.
Publicado: (2018)

Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p
por: Chen, Feng, et al.
Publicado: (2021)

Chemotherapeutic Drug Based Metal–Organic Particles for Microvesicle‐Mediated Deep Penetration and Programmable pH/NIR/Hypoxia Activated Cancer Photochemotherapy
por: Zhang, Da, et al.
Publicado: (2018)

Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma
por: Zhang, Da, et al.
Publicado: (2017)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
por: Li, Ling, et al.
Publicado: (2022)

LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway
por: Liu, Lihui, et al.
Publicado: (2016)

Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials
por: Liu, Hongzhi, et al.
Publicado: (2018)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma
por: Fang, Wentong, et al.
Publicado: (2020)

Universal two‐dimensional labelled probe‐mediated melting curve analysis based on multiplex PCR for rapid typing of Plasmodium in a single closed tube
por: Xu, Haipo, et al.
Publicado: (2023)

Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis
por: Wang, Lei, et al.
Publicado: (2018)

Prognostic Value of MicroRNA-497 in Various Cancers: A Systematic Review and Meta-Analysis
por: Liu, Zhiqiang, et al.
Publicado: (2019)

MicroRNA-601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3
por: Song, Yanan, et al.
Publicado: (2022)

ADAR1-Mediated RNA Editing and Its Role in Cancer
por: Liu, Jizhe, et al.
Publicado: (2022)

Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases
por: Yu, Shaoxiong, et al.
Publicado: (2023)

The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis
por: Wang, Lei, et al.
Publicado: (2017)

Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018)

The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
por: Liu, Juan, et al.
Publicado: (2020)

miR-642 serves as a tumor suppressor in hepatocellular carcinoma by regulating SEMA4C and p38 MAPK signaling pathway
por: Yu, Zaijun, et al.
Publicado: (2020)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_74k4mp6l5or1bqha2202ingro6